| [1] |
Klimova B, Kuca K, Maresova P. Global view on Alzheimer′s disease and diabetes mellitus：threats，risks and treatment[J]．Curr Alzheimer Res，2018，15(14):1277-1282.
|
| [2] |
Schimming C, Luo X, Zhang C, et al. Cognitive performance of older adults in a specialized diabetes clinic[J]．J Diabetes，2017，9(10):929-935.
|
| [3] |
Tang J, Pei Y, Zhou G．When aging-onset diabetes is coming across with Alzheimer disease：comparable pathogenesis and therapy[J]．Exp Gerontol，2013，48(8):744-750.
|
| [4] |
Riederer P, Bartl J, Laux G，et al.Diabetes type Ⅱ：a risk factor for depression-Parkinson-Alzheimer[J]．Neurotox Res，2011，19(2):253-265.
|
| [5] |
Iqbal K, Grundke-Iqbal I．Pharmacological approaches of neurofibrillary degeneration[J]．Curr Alzheimer Res，2005，2(3):335-341.
|
| [6] |
Wang HH, Li Y, Li A，et al.Forskolin induces hyperphosphorylation of tau accompanied by cell cycle reactivation in primary hippocampal neurons[J]．Mol Neurobiol，2018，55(1):696-706.
|
| [7] |
钱荣立．关于糖尿病的新诊断标准与分型[J]．中国糖尿病杂志，2000，8(1):5-6.
|
| [8] |
Association AP.Diagnostic and statistical manual of mental disorders DSM-Ⅳ[M].4th ed.Washington DC：Association AP，1994：142-147.
|
| [9] |
Pasquier F, Boulogne A, Leys D, et al. Diabetes mellitus and dementia[J]．Diabetes Metab，2006，32(5 Pt 1):403-414.
|
| [10] |
De Santi S, de Leon MJ, Rusinek H，et al.Hippocampal formation glucose metabolism and volume losses in MCI and AD[J]．Neurobiol Aging，2001，22(4):529-539.
|
| [11] |
Clodfelder-miller B, De Sarno P, Zmijewska AA，et al.Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3[J]．J Biol Chem，2005，280(48):39723-39731.
|
| [12] |
Yao XQ, Li XC, Zhang XX, et al. Glycogen synthase kinase-3β regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1[J]．FEBS Lett，2012，586(16):2522-2528.
|
| [13] |
Miloso M, Scuteri A, Foudah D，et al.MAPKs as mediators of cell fate determination：an approach to neurodegenerative diseases[J]．Curr Med Chem，2008，15(6):538-548.
|
| [14] |
Paccalin M, Pain-Barc S, Pluchon C，et al.Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer′s disease[J]．Dement Geriatr Cogn Disord，2006，22(4):320-326.
|
| [15] |
Giunta M, Rigamonti AE, Scarpini E，et al.The leukocyte expression of CD36 is low in patients with Alzheimer′s disease and mild cognitive impairment[J]．Neurobiol Aging，2007，28(4):515-518.
|
| [16] |
Mann RK, Bamezai R．Rotein phosphatase-1 inhibition induces high SCEs in normal whole blood cultures[J]．Indian J Exp Biol，1995，33(9):710-711.
|
| [17] |
Giunti D, Borsellino G, Benelli R，et al.Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS[J]．J Leukoc Biol，2003，73(5):584-590.
|
| [18] |
Xu ZP, Yang SL, Zhao S，et al.Biomarkers for early diagnostic of mild cognitive impairment in Type-2 diabetes patients：a multicentre，retrospective，nested case-control study[J]．Ebio Medicine，2016(5):105-113.
|
| [19] |
Exalto LG, van der Flier WM, Scheltens P, et al. Glycemia and levels of cerebrospinal fluid amyloid and tau in patients attending a memory clinic[J]．J Am Geriatr Soc，2010，58(7):1318-1321.
|
| [20] |
李小娥，刘学威，李玉亭．住院2型糖尿病患者血清尿酸水平与血清糖化血红蛋白水平的关系[J/CD]．中华诊断学电子杂志，2018，6(1):65-68.
|